Difference between revisions of "Drug index"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (FDA approval)
 
(282 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 +
<span id="BackToTop"></span>
 +
<div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px; opacity:0.8; border-style: solid; border-color:DarkGray; border-width: 1px">
 +
[[#top|Back to Top]]
 +
</div>
 +
=Guidelines=
 +
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.'''
  
−
=Guidelines=
 
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
'''Other [[#Interesting_and_Helpful_Links|interesting and helpful links]] can be found by clicking the link.'''
 
'''Other [[#Interesting_and_Helpful_Links|interesting and helpful links]] can be found by clicking the link.'''
 
==Chemotherapy safety standards==
 
==Chemotherapy safety standards==
  
−
*'''2020:''' Dillmon et al. [https://doi.org/10.1200/JCO.19.02297 Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards] [https://pubmed.ncbi.nlm.nih.gov/31815576 PubMed]
+
*'''2020:''' Dillmon et al. [https://doi.org/10.1200/JCO.19.02297 Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards] [https://pubmed.ncbi.nlm.nih.gov/31815576/ PubMed]
−
*'''2019:''' Celano et al. [https://doi.org/10.1200/JCO.18.01616 Safe handling of hazardous drugs: ASCO standards] [https://pubmed.ncbi.nlm.nih.gov/30620670 PubMed]
+
*'''2019:''' Celano et al. [https://doi.org/10.1200/JCO.18.01616 Safe handling of hazardous drugs: ASCO standards] [https://pubmed.ncbi.nlm.nih.gov/30620670/ PubMed]
 
*'''2016:''' Neuss et al. [https://doi.org/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology]
 
*'''2016:''' Neuss et al. [https://doi.org/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology]
−
*'''2010:''' Carrington et al. [https://onlinelibrary.wiley.com/doi/10.1111/j.1743-7563.2010.01321.x/full The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy] [https://pubmed.ncbi.nlm.nih.gov/20887505 PubMed]
+
*'''2010:''' Carrington et al. [https://doi.org/10.1111/j.1743-7563.2010.01321.x The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy] [https://pubmed.ncbi.nlm.nih.gov/20887505/ PubMed]
  
 
==Dose adjustments==
 
==Dose adjustments==
 
*'''2021:''' Griggs et al. [https://doi.org/10.1200/jco.21.00471 Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update]
 
*'''2021:''' Griggs et al. [https://doi.org/10.1200/jco.21.00471 Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update]
−
===Older===
+
 
−
*'''2012:''' Griggs et al. [https://doi.org/10.1200/jco.2011.39.9436 Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline]<ref>Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. [https://doi.org/10.1200/jco.2011.39.9436 link to original article] [https://pubmed.ncbi.nlm.nih.gov/22473167 PubMed]</ref>
+
*'''2012:''' Griggs et al. [https://doi.org/10.1200/jco.2011.39.9436 Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline]<ref>Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. [https://doi.org/10.1200/jco.2011.39.9436 link to original article] [https://pubmed.ncbi.nlm.nih.gov/22473167/ PubMed]</ref>
  
 
==Antimicrobials==
 
==Antimicrobials==
Line 27: Line 28:
  
 
=Approved antineoplastics=
 
=Approved antineoplastics=
−
''This section contains drugs that have had at least one formal approval in any domain (FDA, EMA, etc). Biosimilars are also indexed here, indented below their parent compound.''
+
''This section contains anticancer drugs that have had at least one formal approval in any domain (FDA, EMA, etc). Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound. For drugs first approved within the current or prior calendar years, the date of initial approval is also provided here.''
 
==A==
 
==A==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Abarelix (Plenaxis)]]
 
*[[Abarelix (Plenaxis)]]
 
*[[Abemaciclib (Verzenio)]]
 
*[[Abemaciclib (Verzenio)]]
Line 38: Line 36:
 
*[[Acalabrutinib (Calquence)]]
 
*[[Acalabrutinib (Calquence)]]
 
*[[Aclarubicin (Aclacinomycin)]]
 
*[[Aclarubicin (Aclacinomycin)]]
−
*[[Ado-trastuzumab emtansine (Kadcyla)]]
+
*[[Adagrasib (Krazati)]]
 
*[[Afatinib (Gilotrif)]]
 
*[[Afatinib (Gilotrif)]]
 
*[[Aldesleukin (Proleukin)]]
 
*[[Aldesleukin (Proleukin)]]
Line 50: Line 48:
 
*[[Amifostine (Ethyol)]]
 
*[[Amifostine (Ethyol)]]
 
*[[Aminoglutethimide (Cytadren)]]
 
*[[Aminoglutethimide (Cytadren)]]
−
*[[Amivantamab (Rybrevant)]] '''FDA approved 5/21/2021'''
+
*[[Amivantamab (Rybrevant)]]
 
*[[Amrubicin (Calsed)]]
 
*[[Amrubicin (Calsed)]]
 
*[[Amsacrine (Amsidine)]]
 
*[[Amsacrine (Amsidine)]]
 
*[[Anastrozole (Arimidex)]]
 
*[[Anastrozole (Arimidex)]]
 
*[[Ancestim (Stemgen)]]
 
*[[Ancestim (Stemgen)]]
 +
*[[Anlotinib (Fukewei)]]
 
*[[Apalutamide (Erleada)]]
 
*[[Apalutamide (Erleada)]]
 
*[[Apatinib (Aitan)]]
 
*[[Apatinib (Aitan)]]
 
*[[Arsenic trioxide (Trisenox)]]
 
*[[Arsenic trioxide (Trisenox)]]
−
*[[Asciminib (Scemblix)]] '''FDA approved 10/29/2021'''
+
*[[Asciminib (Scemblix)]]
 
*[[Asparaginase Erwinia chrysanthemi (Erwinaze)]]
 
*[[Asparaginase Erwinia chrysanthemi (Erwinaze)]]
−
**[[Asparaginase erwinia chrysanthemi-rywn (Rylaze)]] '''FDA approved 6/30/2021'''
+
**[[Asparaginase erwinia chrysanthemi-rywn (Rylaze)]]
 
*[[Atezolizumab (Tecentriq)]]
 
*[[Atezolizumab (Tecentriq)]]
 +
*[[Aumolertinib (Amelie)]]
 
*[[Avapritinib (Ayvakit)]]
 
*[[Avapritinib (Ayvakit)]]
 
*[[Avelumab (Bavencio)]]
 
*[[Avelumab (Bavencio)]]
Line 70: Line 70:
  
 
==B==
 
==B==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
−
*[[Bacillus Calmette-Guérin (BCG)]]
+
 
 +
*[[BCG vaccine]]
 
*[[Belantamab mafodotin (Blenrep)]]
 
*[[Belantamab mafodotin (Blenrep)]]
 
*[[Belinostat (Beleodaq)]]
 
*[[Belinostat (Beleodaq)]]
 
*[[Belotecan (Camptobell)]]
 
*[[Belotecan (Camptobell)]]
−
*[[Belumosudil (Rezurock)]] '''FDA approved 7/16/2021'''
+
*[[Belumosudil (Rezurock)]]
−
*[[Belzutifan (Welireg)]] '''FDA approved 8/13/2021'''
+
*[[Belzutifan (Welireg)]]
 
*[[Bendamustine]]
 
*[[Bendamustine]]
 
*[[Benralizumab (Fasenra)]]
 
*[[Benralizumab (Fasenra)]]
 
*[[Bevacizumab (Avastin)]]
 
*[[Bevacizumab (Avastin)]]
 +
**[[Bevacizumab-adcd (Vegzelga)]]
 +
**[[Bevacizumab-aveg (Avegra)]]
 
**[[Bevacizumab-awwb (Mvasi)]]
 
**[[Bevacizumab-awwb (Mvasi)]]
 +
**[[Bevacizumab-aybi (Aybintio)]]
 
**[[Bevacizumab-bvzr (Zirabev)]]
 
**[[Bevacizumab-bvzr (Zirabev)]]
−
**[[Bevacizumab (Alymsys/Oyavas)]]
+
**[[Bevacizumab-equi (Equidacent)]]
−
**[[Bevacizumab (Aybintio)]]
+
**[[Bevacizumab-maly (Alymsys)]]
−
**[[Bevacizumab (Equidacent)]]
+
**[[Bevacizumab-onbe (Onbevzi)]]
−
**[[Bevacizumab (Onbevzi)]]
+
**[[Bevacizumab-tnjn (Avzivi)]] '''FDA approved 2023-12'''
 
*[[Bexarotene (Targretin)]]
 
*[[Bexarotene (Targretin)]]
 
*[[Bicalutamide (Casodex)]]
 
*[[Bicalutamide (Casodex)]]
−
*[[Binimetinib (Mektovi)]]
+
*[[Binimetinib (Mektovi)]]
 
*[[Bleomycin (Blenoxane)]]
 
*[[Bleomycin (Blenoxane)]]
 
*[[Blinatumomab (Blincyto)]]
 
*[[Blinatumomab (Blincyto)]]
 +
*[[Borofalan-10B (Steboronine)]]
 
*[[Bortezomib (Velcade)]]
 
*[[Bortezomib (Velcade)]]
 
*[[Bosutinib (Bosulif)]]
 
*[[Bosutinib (Bosulif)]]
Line 104: Line 105:
  
 
==C==
 
==C==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Cabazitaxel (Jevtana)]]
 
*[[Cabazitaxel (Jevtana)]]
Line 113: Line 111:
 
*[[Cabozantinib (Cometriq)]]
 
*[[Cabozantinib (Cometriq)]]
 
*[[Calaspargase (Asparlas)]]
 
*[[Calaspargase (Asparlas)]]
 +
*[[Camrelizumab (AiRuiKa)]]
 
*[[Capecitabine (Xeloda)]]
 
*[[Capecitabine (Xeloda)]]
 +
*[[Capivasertib (Truqap)]] '''FDA approved 2023-11-16'''
 
*[[Caplacizumab (Cablivi)]]
 
*[[Caplacizumab (Cablivi)]]
 
*[[Capmatinib (Tabrecta)]]
 
*[[Capmatinib (Tabrecta)]]
 
*[[Carboplatin (Paraplatin)]]
 
*[[Carboplatin (Paraplatin)]]
 
*[[Carfilzomib (Kyprolis)]]
 
*[[Carfilzomib (Kyprolis)]]
 +
*[[Carmofur (HCFU)]]
 
*[[Carmustine (BCNU)]]
 
*[[Carmustine (BCNU)]]
 
*[[Carmustine wafer, polifeprosan 20 (Gliadel)]]
 
*[[Carmustine wafer, polifeprosan 20 (Gliadel)]]
−
*[[Caspofungin (Cancidas)]]
 
 
*[[Cemiplimab (Libtayo)]]
 
*[[Cemiplimab (Libtayo)]]
 
*[[Ceritinib (Zykadia)]]
 
*[[Ceritinib (Zykadia)]]
Line 127: Line 127:
 
*[[Chlorambucil (Leukeran)]]
 
*[[Chlorambucil (Leukeran)]]
 
*[[Chlorozotocin (DCNU)]]
 
*[[Chlorozotocin (DCNU)]]
−
*[[Ciltacabtagene autoleucel (Carvykti)]] '''FDA approved 3/1/2022'''
+
*[[Ciltacabtagene autoleucel (Carvykti)]]
 
*[[Cisplatin (Platinol)]]
 
*[[Cisplatin (Platinol)]]
 
*[[Cladribine (Leustatin)]]
 
*[[Cladribine (Leustatin)]]
Line 142: Line 142:
  
 
==D==
 
==D==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Dabrafenib (Tafinlar)]]
 
*[[Dabrafenib (Tafinlar)]]
Line 153: Line 150:
 
*[[Daratumumab (Darzalex)]]
 
*[[Daratumumab (Darzalex)]]
 
*[[Daratumumab and hyaluronidase (Darzalex Faspro)]]
 
*[[Daratumumab and hyaluronidase (Darzalex Faspro)]]
 +
*[[Daratumumab and vorhyaluronidase (Darzquro)]]
 +
*[[Darinaparsin (Darvias)]]
 
*[[Darolutamide (Nubeqa)]]
 
*[[Darolutamide (Nubeqa)]]
 
*[[Dasatinib (Sprycel)]]
 
*[[Dasatinib (Sprycel)]]
Line 161: Line 160:
 
*[[Dexamethasone (Decadron)]]
 
*[[Dexamethasone (Decadron)]]
 
*[[Dinutuximab (Unituxin)]]
 
*[[Dinutuximab (Unituxin)]]
 +
*[[Dinutuximab beta (Qarziba)]]
 
*[[Docetaxel (Taxotere)]]
 
*[[Docetaxel (Taxotere)]]
−
*[[Dostarlimab (Jemperli)]] '''FDA approved 4/22/2021'''
+
*[[Donafenib (Zepsun)]]
 +
*[[Dostarlimab (Jemperli)]]
 
*[[Doxifluridine (Didox)]]
 
*[[Doxifluridine (Didox)]]
 
*[[Doxorubicin (Adriamycin)]]
 
*[[Doxorubicin (Adriamycin)]]
−
*[[Pegylated liposomal doxorubicin (Doxil)]]
 
 
*[[Durvalumab (Imfinzi)]]
 
*[[Durvalumab (Imfinzi)]]
 
*[[Dutasteride (Avodart)]]
 
*[[Dutasteride (Avodart)]]
Line 171: Line 171:
  
 
==E==
 
==E==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Eflornithine (Iwilfin)]] '''FDA approved 2023-12-13'''
−
|-
+
*[[Elacestrant (Orserdu)]] '''FDA approved 2023-01-27'''
−
|[[#top|back to top]]
 
−
|}
 
−
 
 
 
*[[Elotuzumab (Empliciti)]]
 
*[[Elotuzumab (Empliciti)]]
 +
*[[Elranatamab (Elrexfio)]] '''FDA approved on 2023-08-14'''
 
*[[Emapalumab (Gamifant)]]
 
*[[Emapalumab (Gamifant)]]
 
*[[Enasidenib (Idhifa)]]
 
*[[Enasidenib (Idhifa)]]
 
*[[Encorafenib (Braftovi)]]
 
*[[Encorafenib (Braftovi)]]
 
*[[Enfortumab vedotin (Padcev)]]
 
*[[Enfortumab vedotin (Padcev)]]
 +
*[[Ensartinib (Ensacove)]]
 
*[[Entrectinib (Rozlytrek)]]
 
*[[Entrectinib (Rozlytrek)]]
 +
*[[Envafolimab (Enweida)]]
 
*[[Enzalutamide (Xtandi)]]
 
*[[Enzalutamide (Xtandi)]]
 +
*[[Epcoritamab (Epkinly)]] '''FDA approved 2023-05-19'''
 
*[[Epirubicin (Ellence)]]
 
*[[Epirubicin (Ellence)]]
 
*[[Erdafitinib (Balversa)]]
 
*[[Erdafitinib (Balversa)]]
Line 194: Line 195:
  
 
==F==
 
==F==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Fadrozole (Afema)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
−
*[[Fam-trastuzumab deruxtecan (Enhertu)]]
 
 
*[[Fedratinib (Inrebic)]]
 
*[[Fedratinib (Inrebic)]]
 
*[[Fluorouracil (5-FU)]]
 
*[[Fluorouracil (5-FU)]]
 
*[[Fludarabine (Fludara)]]
 
*[[Fludarabine (Fludara)]]
 +
*[[Flumatinib (Xinfu)]]
 
*[[Flutamide (Eulexin)]]
 
*[[Flutamide (Eulexin)]]
−
*[[Folinic acid (Leucovorin)]]
+
*[[Leucovorin (Folinic acid)]]
 +
*[[Forodesine (Fodosine)]]
 
*[[Fostamatinib (Tavalisse)]]
 
*[[Fostamatinib (Tavalisse)]]
 +
*[[Fotemustine (Muphoran)]]
 +
*[[Fruquintinib (Elunate)]]
 
*[[Fulvestrant (Faslodex)]]
 
*[[Fulvestrant (Faslodex)]]
 +
*[[Furmonertinib (Ivesa)]]
 +
*[[Futibatinib (Lytgobi)]]
  
 
==G==
 
==G==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
−
*[[Gallium Ga 68 gozetotide (Locametz)]] '''FDA approved 3/23/2022'''
+
 
 +
*[[Gallium Ga 68 gozetotide (Locametz)]]
 
*[[Gefitinib (Iressa)]]
 
*[[Gefitinib (Iressa)]]
 
*[[Gemcitabine (Gemzar)]]
 
*[[Gemcitabine (Gemzar)]]
Line 219: Line 219:
 
*[[Gilteritinib (Xospata)]]
 
*[[Gilteritinib (Xospata)]]
 
*[[Glasdegib (Daurismo)]]
 
*[[Glasdegib (Daurismo)]]
 +
*[[Glofitamab (Columvi)]] '''FDA approved 2023-06-15'''
 
*[[Goserelin (Zoladex)]]
 
*[[Goserelin (Zoladex)]]
  
 
==H==
 
==H==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Heptaplatin (SunPla)]]
−
|-
+
*[[Histamine dihydrochloride (Ceplene)]]
−
|[[#top|back to top]]
 
−
|}
 
−
 
 
−
*[[Heptaplatin (Sunpla)]]
 
 
*[[Histrelin (Vantas)]]
 
*[[Histrelin (Vantas)]]
 
*[[Hydrocortisone (Cortef)]]
 
*[[Hydrocortisone (Cortef)]]
Line 233: Line 230:
  
 
==I==
 
==I==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Ibritumomab tiuxetan (Zevalin)]]
 
*[[Ibritumomab tiuxetan (Zevalin)]]
Line 242: Line 236:
 
*[[Icotinib (Conmana)]]
 
*[[Icotinib (Conmana)]]
 
*[[Idarubicin (Idamycin)]]
 
*[[Idarubicin (Idamycin)]]
−
*[[Idecabtagene vicleucel (Abecma)]] '''FDA approved 3/26/2021'''
+
*[[Idecabtagene vicleucel (Abecma)]]
 
*[[Idelalisib (Zydelig)]]
 
*[[Idelalisib (Zydelig)]]
 
*[[Ifosfamide (Ifex)]]
 
*[[Ifosfamide (Ifex)]]
 
*[[Imatinib (Gleevec)]]
 
*[[Imatinib (Gleevec)]]
−
*[[Infigratinib (Truseltiq)]] '''FDA approved 5/28/2021'''
+
*[[Imetelstat (Rytelo)]] '''FDA approved 2024-06-06'''
 +
*[[Infigratinib (Truseltiq)]]
 
*[[Inotuzumab ozogamicin (Besponsa)]]
 
*[[Inotuzumab ozogamicin (Besponsa)]]
 
*[[Interferon alfa-2a (Roferon-A)]]
 
*[[Interferon alfa-2a (Roferon-A)]]
 
*[[Interferon alfa-2b (Intron-A)]]
 
*[[Interferon alfa-2b (Intron-A)]]
 +
*[[Interferon gamma-1a (Imunomax-γ)]]
 
*[[Interferon gamma-1b (Actimmune)]]
 
*[[Interferon gamma-1b (Actimmune)]]
 
*[[Iobenguane I 131 (Azedra)]]
 
*[[Iobenguane I 131 (Azedra)]]
 
*[[Iodine-131]]
 
*[[Iodine-131]]
 
*[[Ipilimumab (Yervoy)]]
 
*[[Ipilimumab (Yervoy)]]
−
*[[Iptacopan (LNP023)]]
 
 
*[[Irinotecan (Camptosar)]]
 
*[[Irinotecan (Camptosar)]]
 
*[[Irinotecan liposome (Onivyde)]]
 
*[[Irinotecan liposome (Onivyde)]]
Line 268: Line 263:
  
 
==L==
 
==L==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Lanreotide (Somatuline)]]
 
*[[Lanreotide (Somatuline)]]
 
*[[Lanreotide LAR (Somatuline Depot)]]
 
*[[Lanreotide LAR (Somatuline Depot)]]
 
*[[Lapatinib (Tykerb)]]
 
*[[Lapatinib (Tykerb)]]
 
*[[Larotrectinib (Vitrakvi)]]
 
*[[Larotrectinib (Vitrakvi)]]
−
*[[Lasofoxifene (Fablyn)]] '''not FDA approved'''
+
*[[Lasofoxifene (Fablyn)]]
 
*[[Lenalidomide (Revlimid)]]
 
*[[Lenalidomide (Revlimid)]]
 
*[[Lenvatinib (Lenvima)]]
 
*[[Lenvatinib (Lenvima)]]
−
*[[Letermovir (Prevymis)]]
 
 
*[[Letrozole (Femara)]]
 
*[[Letrozole (Femara)]]
 
*[[Leuprolide (Lupron)]]
 
*[[Leuprolide (Lupron)]]
 
*[[Levoleucovorin (Fusilev)]]
 
*[[Levoleucovorin (Fusilev)]]
−
*[[Lisocabtagene maraleucel (Breyanzi)]] '''FDA approved 2/5/2021'''
+
*[[Lifileuecel (Contego)]] '''FDA approved 2024-02-16'''
 +
*[[Lisocabtagene maraleucel (Breyanzi)]]
 
*[[Lobaplatin (D-19466)]]
 
*[[Lobaplatin (D-19466)]]
 
*[[Lomustine (CCNU)]]
 
*[[Lomustine (CCNU)]]
−
*[[Loncastuximab tesirine (Zynlonta)]] '''FDA approved 4/23/2021'''
+
*[[Loncastuximab tesirine (Zynlonta)]]
 
*[[Lorlatinib (Lorbrena)]]
 
*[[Lorlatinib (Lorbrena)]]
 
*[[Lurbinectedin (Zepzelca)]]
 
*[[Lurbinectedin (Zepzelca)]]
 
*[[Lutetium Lu 177 dotatate (Lutathera)]]
 
*[[Lutetium Lu 177 dotatate (Lutathera)]]
−
*[[Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)]] '''FDA approved 3/23/2022'''
+
*[[Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)]]
  
 
==M==
 
==M==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Margetuximab (Margenza)]]
 
*[[Margetuximab (Margenza)]]
 
*[[Mechlorethamine (Mustargen)]]
 
*[[Mechlorethamine (Mustargen)]]
−
*[[Medroxyprogesterone (MPA)]]
+
*[[Medroxyprogesterone acetate (MPA)]]
 
*[[Megestrol (Megace)]]
 
*[[Megestrol (Megace)]]
 
*[[Melphalan (Alkeran)]]
 
*[[Melphalan (Alkeran)]]
 +
*[[Melphalan for Injection-Hepatic Delivery System (Hepzato Kit)]] '''FDA approved on 2023-08-14'''
 
*[[Mepolizumab (Nucala)]]
 
*[[Mepolizumab (Nucala)]]
 
*[[Mercaptopurine (6-MP)]]
 
*[[Mercaptopurine (6-MP)]]
Line 309: Line 299:
 
*[[Midostaurin (Rydapt)]]
 
*[[Midostaurin (Rydapt)]]
 
*[[Mifamurtide (Mepact)]]
 
*[[Mifamurtide (Mepact)]]
−
*[[Mitomycin (Jelmyto)]]
+
*[[Miriplatin (Miripla)]]
 +
*[[Mirvetuximab soravtansine (Elahere)]]
 +
*[[Mitomycin pyelocalyceal (Jelmyto)]]
 
*[[Mitomycin (Mutamycin)]]
 
*[[Mitomycin (Mutamycin)]]
 
*[[Mitotane (Lysodren)]]
 
*[[Mitotane (Lysodren)]]
 
*[[Mitoxantrone (Novantrone)]]
 
*[[Mitoxantrone (Novantrone)]]
−
*[[Mobocertinib (Exkivity)]] '''FDA approved on 9/15/2021'''
+
*[[Mobocertinib (Exkivity)]]
 
*[[Mogamulizumab (Poteligeo)]]
 
*[[Mogamulizumab (Poteligeo)]]
 +
*[[Momelotinib (Ojjaara)]] '''FDA approved 2023-09-15'''
 +
*[[Mosunetuzumab (Lunsumio)]]
 
*[[Moxetumomab pasudotox (Lumoxiti)]]
 
*[[Moxetumomab pasudotox (Lumoxiti)]]
  
 
==N==
 
==N==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Nadofaragene firadenovec (Adstiladrin)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
−
 
 
 
*[[Naxitamab (Danyelza)]]
 
*[[Naxitamab (Danyelza)]]
 
*[[Necitumumab (Portrazza)]]
 
*[[Necitumumab (Portrazza)]]
 
*[[Nedaplatin (Aqupla)]]
 
*[[Nedaplatin (Aqupla)]]
 
*[[Nelarabine (Arranon)]]
 
*[[Nelarabine (Arranon)]]
−
*[[NEOD001]]
 
 
*[[Neratinib (Nerlynx)]]
 
*[[Neratinib (Nerlynx)]]
 
*[[Nilotinib (Tasigna)]]
 
*[[Nilotinib (Tasigna)]]
Line 335: Line 324:
 
*[[Nintedanib (Vargatef)]]
 
*[[Nintedanib (Vargatef)]]
 
*[[Niraparib (Zejula)]]
 
*[[Niraparib (Zejula)]]
 +
*[[Niraparib and abiraterone (Akeega)]] '''FDA approved 2023-08-11'''
 +
*[[Nirogacestat (Ogsiveo)]] '''FDA approved 2023-11-27'''
 
*[[Nivolumab (Opdivo)]]
 
*[[Nivolumab (Opdivo)]]
−
*[[Nivolumab and relatlimab (Opdualag)]] '''FDA approved 3/18/2022'''
+
*[[Nivolumab and relatlimab (Opdualag)]]
−
*[[Nolatrexed (Thymitaq)]]
+
*[[Nogapendekin alfa inbakicept (Anktiva)]] '''FDA approved 2024-04-22'''
 
*[[Non-pegylated liposomal doxorubicin (Myocet)]]
 
*[[Non-pegylated liposomal doxorubicin (Myocet)]]
 
*[[Norethandrolone (Nilevar)]]
 
*[[Norethandrolone (Nilevar)]]
Line 343: Line 334:
  
 
==O==
 
==O==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Obinutuzumab (Gazyva)]]
 
*[[Obinutuzumab (Gazyva)]]
 
*[[Octreotide (Sandostatin)]]
 
*[[Octreotide (Sandostatin)]]
Line 352: Line 340:
 
*[[Ofatumumab (Arzerra)]]
 
*[[Ofatumumab (Arzerra)]]
 
*[[Olaparib (Lynparza)]]
 
*[[Olaparib (Lynparza)]]
 +
*[[Olutasidenib (Rezlidhia)]]
 +
*[[Olverembatinib (HQP-1351)]]
 
*[[Omacetaxine (Synribo)]]
 
*[[Omacetaxine (Synribo)]]
 
*[[Osimertinib (Tagrisso)]]
 
*[[Osimertinib (Tagrisso)]]
Line 357: Line 347:
  
 
==P==
 
==P==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Paclitaxel (Taxol)]]
 
*[[Paclitaxel (Taxol)]]
 
*[[Paclitaxel, nanoparticle albumin-bound (Abraxane)]]
 
*[[Paclitaxel, nanoparticle albumin-bound (Abraxane)]]
 
*[[Paclitaxel, polymeric micelle-bound (Genexol-PM)]]
 
*[[Paclitaxel, polymeric micelle-bound (Genexol-PM)]]
 +
*[[Pacritinib (Vonjo)]]
 +
*[[Padeliporfin (Tookad)]]
 
*[[Palbociclib (Ibrance)]]
 
*[[Palbociclib (Ibrance)]]
 
*[[Panitumumab (Vectibix)]]
 
*[[Panitumumab (Vectibix)]]
Line 372: Line 361:
 
*[[Peginterferon alfa-2a (Pegasys)]]
 
*[[Peginterferon alfa-2a (Pegasys)]]
 
*[[Peginterferon alfa-2b (Sylatron)]]
 
*[[Peginterferon alfa-2b (Sylatron)]]
 +
*[[Pegylated liposomal doxorubicin (Doxil)]]
 
*[[Pembrolizumab (Keytruda)]]
 
*[[Pembrolizumab (Keytruda)]]
 
*[[Pemetrexed (Alimta)]]
 
*[[Pemetrexed (Alimta)]]
 
*[[Pemigatinib (Pemazyre)]]
 
*[[Pemigatinib (Pemazyre)]]
 +
*[[Penpulimab (Anniko)]]
 
*[[Pentostatin (Nipent)]]
 
*[[Pentostatin (Nipent)]]
 
*[[Pertuzumab (Perjeta)]]
 
*[[Pertuzumab (Perjeta)]]
−
*[[Pertuzumab & Trastuzumab hyaluronidase (Phesgo)]]
+
*[[Pertuzumab and Trastuzumab hyaluronidase (Phesgo)]]
 
*[[Pexidartinib (Turalio)]]
 
*[[Pexidartinib (Turalio)]]
 +
*[[Pipobroman (Vercyte)]]
 
*[[Pirarubicin (THP)]]
 
*[[Pirarubicin (THP)]]
 +
*[[Pirtobrutinib (Jaypirca)]] '''FDA approved 2023-01-27'''
 
*[[Pixantrone (Pixuvri)]]
 
*[[Pixantrone (Pixuvri)]]
 
*[[Polatuzumab vedotin (Polivy)]]
 
*[[Polatuzumab vedotin (Polivy)]]
Line 390: Line 383:
 
*[[Prednisolone (Millipred)]]
 
*[[Prednisolone (Millipred)]]
 
*[[Procarbazine (Matulane)]]
 
*[[Procarbazine (Matulane)]]
 +
*[[Pyrotinib (Irene)]]
 +
 +
==Q==
 +
*[[Quizartinib (Vanflyta)]]
  
 
==R==
 
==R==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Racotumomab (Vaxira)]]
−
|-
+
*[[Radium-223 (Xofigo)]]
−
|[[#top|back to top]]
 
−
|}
 
−
 
 
−
*[[Radium Ra 223 (Xofigo)]]
 
 
*[[Radotinib (Supect)]]
 
*[[Radotinib (Supect)]]
 
*[[Raltitrexed (Tomudex)]]
 
*[[Raltitrexed (Tomudex)]]
Line 406: Line 399:
 
*[[Regorafenib (Stivarga)]]
 
*[[Regorafenib (Stivarga)]]
 
*[[Relugolix (Orgovyx)]]
 
*[[Relugolix (Orgovyx)]]
 +
*[[Repotrectinib (Augtyro)]] '''FDA approved 2023-11-15'''
 +
*[[Retifanlimab (Zynyz)]] '''FDA approved 2023-03-22'''
 
*[[Ribociclib (Kisqali)]]
 
*[[Ribociclib (Kisqali)]]
 
*[[Ripretinib (Qinlock)]]
 
*[[Ripretinib (Qinlock)]]
Line 412: Line 407:
 
**[[Rituximab-arrx (Riabni)]]
 
**[[Rituximab-arrx (Riabni)]]
 
**[[Rituximab-pvvr (Ruxience)]]
 
**[[Rituximab-pvvr (Ruxience)]]
−
**[[Rituximab (Blitzima)]]
+
**[[Rituximab-blit (Blitzima)]]
−
**[[Rituximab (Ritemvia)]]
+
**[[Rituximab-rite (Ritemvia)]]
−
**[[Rituximab (Rixathon)]]
+
**[[Rituximab-rixa (Rixathon)]]
−
**[[Rituximab (Riximyo)]]
+
**[[Rituximab-rixi (Riximyo)]]
−
*[[Rituximab and hyaluronidase human (Rituximab Hycela)]]
+
*[[Rituximab and hyaluronidase human (Rituxan Hycela)]]
 
*[[Romidepsin (Istodax)]]
 
*[[Romidepsin (Istodax)]]
 +
*[[Ropeginterferon alfa-2b (Besremi)]]
 
*[[Rucaparib (Rubraca)]]
 
*[[Rucaparib (Rubraca)]]
 
*[[Ruxolitinib (Jakafi)]]
 
*[[Ruxolitinib (Jakafi)]]
  
 
==S==
 
==S==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Sacituzumab govitecan (Trodelvy)]]
 
*[[Sacituzumab govitecan (Trodelvy)]]
Line 432: Line 425:
 
*[[Selpercatinib (Retevmo)]]
 
*[[Selpercatinib (Retevmo)]]
 
*[[Selumetinib (Koselugo)]]
 
*[[Selumetinib (Koselugo)]]
 +
*[[Serplulimab (Hansizhuang)]]
 +
*[[Sintilimab (Tyvyt)]]
 
*[[Sipuleucel-T (Provenge)]]
 
*[[Sipuleucel-T (Provenge)]]
−
*[[Sirolimus protein-bound particles (Fyarro)]] '''FDA approved 11/22/2021'''
+
*[[Sirolimus protein-bound particles (Fyarro)]]
 
*[[Sonidegib (Odomzo)]]
 
*[[Sonidegib (Odomzo)]]
 
*[[Sorafenib (Nexavar)]]
 
*[[Sorafenib (Nexavar)]]
−
*[[Sotorasib (Lumakras)]] '''FDA approved 5/28/2021'''
+
*[[Sotorasib (Lumakras)]]
 
*[[Stilbamidine]]
 
*[[Stilbamidine]]
 
*[[Streptozocin (Zanosar)]]
 
*[[Streptozocin (Zanosar)]]
 
*[[Strontium-89 (Metastron)]]
 
*[[Strontium-89 (Metastron)]]
 +
*[[Sugemalimab (Cejemly)]]
 
*[[Sunitinib (Sutent)]]
 
*[[Sunitinib (Sutent)]]
 
*[[Suramin (Antrypol)]]
 
*[[Suramin (Antrypol)]]
  
 
==T==
 
==T==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Tabelecleucel (Ebvallo)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Tafasitamab (Monjuvi)]]
 
*[[Tafasitamab (Monjuvi)]]
 
*[[Tagraxofusp (Elzonris)]]
 
*[[Tagraxofusp (Elzonris)]]
 
*[[Talazoparib (Talzenna)]]
 
*[[Talazoparib (Talzenna)]]
 
*[[Talimogene laherparepvec (Imlygic)]]
 
*[[Talimogene laherparepvec (Imlygic)]]
 +
*[[Taloporfin (Laserphyrin)]]
 +
*[[Talquetamab (Talvey)]] '''FDA approved 2023-08-09'''
 +
*[[Tamibarotene (Amnoid)]]
 
*[[Tamoxifen (Nolvadex)]]
 
*[[Tamoxifen (Nolvadex)]]
 +
*[[Tarlatamab (Imdelltra)]] '''FDA approved 2024-05-16'''
 
*[[Tasonermin (Beromun)]]
 
*[[Tasonermin (Beromun)]]
 
*[[Tazemetostat (Tazverik)]]
 
*[[Tazemetostat (Tazverik)]]
 +
*[[Tebentafusp (Kimmtrak)]]
 +
*[[Teclistamab (Tecvayli)]]
 
*[[Tegafur and uracil (UFT)]]
 
*[[Tegafur and uracil (UFT)]]
 
*[[Tegafur, gimeracil, oteracil (Teysuno, S-1)]]
 
*[[Tegafur, gimeracil, oteracil (Teysuno, S-1)]]
−
*[[Telotristat (Xermelo)]]
+
*[[Temoporfin (Foscan)]]
 
*[[Temozolomide (Temodar)]]
 
*[[Temozolomide (Temodar)]]
 
*[[Temsirolimus (Torisel)]]
 
*[[Temsirolimus (Torisel)]]
 
*[[Teniposide (Vumon)]]
 
*[[Teniposide (Vumon)]]
−
*[[Tepotinib (Tepmetko)]] '''FDA approved 2/3/2021'''
+
*[[Tepotinib (Tepmetko)]]
 
*[[Thalidomide (Thalomid)]]
 
*[[Thalidomide (Thalomid)]]
 
*[[Thioguanine (Tabloid)]]
 
*[[Thioguanine (Tabloid)]]
 
*[[Thiotepa (Tepadina)]]
 
*[[Thiotepa (Tepadina)]]
 
*[[Thiotepa (Thioplex)]]
 
*[[Thiotepa (Thioplex)]]
 +
*[[Tirabrutinib (Velexbru)]]
 
*[[Tisagenlecleucel (Kymriah)]]
 
*[[Tisagenlecleucel (Kymriah)]]
−
*[[Tisotumab vedotin (Tivdak)]] '''FDA approved 9/20/2021'''
+
*[[Tisotumab vedotin (Tivdak)]]
 
*[[Topotecan (Hycamtin)]]
 
*[[Topotecan (Hycamtin)]]
 
*[[Toremifene (Fareston)]]
 
*[[Toremifene (Fareston)]]
 +
*[[Toripalimab (Loqtorzi)]] '''FDA approved 2023-10-27'''
 
*[[Tositumomab and I-131 (Bexxar)]]
 
*[[Tositumomab and I-131 (Bexxar)]]
 +
*[[Tovorafenib (Ojemda)]] '''FDA approved 2024-04-23'''
 
*[[Trabectedin (Yondelis)]]
 
*[[Trabectedin (Yondelis)]]
 
*[[Trametinib (Mekinist)]]
 
*[[Trametinib (Mekinist)]]
Line 477: Line 479:
 
**[[Trastuzumab-dkst (Ogivri)]]
 
**[[Trastuzumab-dkst (Ogivri)]]
 
**[[Trastuzumab-dttb (Ontruzant)]]
 
**[[Trastuzumab-dttb (Ontruzant)]]
 +
**[[Trastuzumab-herw (Herwenda)]]
 
**[[Trastuzumab-pkrb (Herzuma)]]
 
**[[Trastuzumab-pkrb (Herzuma)]]
 
**[[Trastuzumab-qyyp (Trazimera)]]
 
**[[Trastuzumab-qyyp (Trazimera)]]
−
**[[Trastuzumab (Zercepac)]]
+
**[[Trastuzumab-strf (Hercessi)]] '''FDA approved 2024-04-29'''
 +
**[[Trastuzumab-zerc (Zercepac)]]
 
*[[Trastuzumab and hyaluronidase (Herceptin Hylecta)]]
 
*[[Trastuzumab and hyaluronidase (Herceptin Hylecta)]]
 +
*[[Trastuzumab deruxtecan (Enhertu)]]
 +
*[[Trastuzumab emtansine (Kadcyla)]]
 +
*[[Tremelimumab (Imjudo)]]
 
*[[Treosulfan (Ovastat)]]
 
*[[Treosulfan (Ovastat)]]
 
*[[Trifluridine and tipiracil (Lonsurf)]]
 
*[[Trifluridine and tipiracil (Lonsurf)]]
Line 486: Line 493:
 
*[[Trimetrexate (Neutrexin)]]
 
*[[Trimetrexate (Neutrexin)]]
 
*[[Triptorelin (Trelstar LA)]]
 
*[[Triptorelin (Trelstar LA)]]
 +
*[[Trofosfamide (Ixoten)]]
 
*[[Tucatinib (Tukysa)]]
 
*[[Tucatinib (Tukysa)]]
  
 
==U==
 
==U==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Ublituximab (Briumvi)]] '''FDA approved 2023-01-06'''
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
−
*[[Umbralisib (Ukoniq)]] '''FDA approved 2/5/2021'''
 
−
 
 
 
==V==
 
==V==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Valemetostat (Ezharmia)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Valrubicin (Valstar)]]
 
*[[Valrubicin (Valstar)]]
 
*[[Vandetanib (Caprelsa)]]
 
*[[Vandetanib (Caprelsa)]]
Line 506: Line 506:
 
*[[Vinblastine (Velban)]]
 
*[[Vinblastine (Velban)]]
 
*[[Vincristine (Oncovin)]]
 
*[[Vincristine (Oncovin)]]
−
*[[Vincristine liposomal (Marqibo)]]
 
 
*[[Vindesine (Eldisine)]]
 
*[[Vindesine (Eldisine)]]
 
*[[Vinflunine (Javlor)]]
 
*[[Vinflunine (Javlor)]]
Line 515: Line 514:
  
 
==Z==
 
==Z==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Zanubrutinib (Brukinsa)]]
 
*[[Zanubrutinib (Brukinsa)]]
 +
*[[Zimberelimab (Yu Duo)]]
 
*[[Ziv-aflibercept (Zaltrap)]]
 
*[[Ziv-aflibercept (Zaltrap)]]
 +
**[[Aflibercept-jbvf (Yesafili)]] '''FDA approved 2024-05'''
 +
**[[Aflibercept-yszy (Opuviz)]] '''FDA approved 2024-05'''
  
 
=Discontinued antineoplastics=
 
=Discontinued antineoplastics=
Line 526: Line 525:
  
 
==A==
 
==A==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Aminopterin]]
 
*[[Aminopterin]]
 
*[[Asparaginase (Elspar)]]
 
*[[Asparaginase (Elspar)]]
  
 
==D==
 
==D==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Daunorubicin liposomal (DaunoXome)]]
 
*[[Daunorubicin liposomal (DaunoXome)]]
 
*[[Denileukin diftitox (Ontak)]]
 
*[[Denileukin diftitox (Ontak)]]
Line 543: Line 536:
  
 
==E==
 
==E==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Edrecolomab (Panorex)]]
 
*[[Edrecolomab (Panorex)]]
 +
*[[Ethinylestradiol]]
  
 
==F==
 
==F==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Floxuridine (FUDR)]]
 
*[[Floxuridine (FUDR)]]
 
*[[Fluoxymesterone (Halotestin)]]
 
*[[Fluoxymesterone (Halotestin)]]
Line 559: Line 547:
  
 
==L==
 
==L==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Levamisole (Ergamisol)]]
 
*[[Levamisole (Ergamisol)]]
  
 
==M==
 
==M==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Melphalan flufenamide (Pepaxto)]]
 
*[[Melphalan flufenamide (Pepaxto)]]
  
 
==O==
 
==O==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Olaratumab (Lartruvo)]]
 
*[[Olaratumab (Lartruvo)]]
  
 
==P==
 
==P==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Paclitaxel poliglumex (Opaxio)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Plicamycin (Mithracin)]]
 
*[[Plicamycin (Mithracin)]]
 +
*[[Polyestradiol phosphate (Estradurin)]]
  
 
==S==
 
==S==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Semustine (MeCCNU)]]
 
*[[Semustine (MeCCNU)]]
  
 
==T==
 
==T==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Testolactone (Teslac)]]
 
*[[Testolactone (Teslac)]]
 +
*[[Triethylenemelamine (Tretamine)]]
  
 
==U==
 
==U==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Umbralisib (Ukoniq)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Uracil mustard]]
 
*[[Uracil mustard]]
 
*[[Urethane]]
 
*[[Urethane]]
 +
 +
==V==
 +
*[[Vincristine liposomal (Marqibo)]]
  
 
=Investigational antineoplastics=
 
=Investigational antineoplastics=
 
''This list is far from exhaustive. Drugs are included here generally once there are some encouraging preliminary results. Since is it very difficult to tell when a company has stopped development on a drug, this list may also include drugs that are no longer under investigation.''
 
''This list is far from exhaustive. Drugs are included here generally once there are some encouraging preliminary results. Since is it very difficult to tell when a company has stopped development on a drug, this list may also include drugs that are no longer under investigation.''
 
==A==
 
==A==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Abexinostat (PCI-24781)]]
 
*[[Abexinostat (PCI-24781)]]
 
*[[Actinium Ac 225 lintuzumab (Actimab-A)]]
 
*[[Actinium Ac 225 lintuzumab (Actimab-A)]]
−
*[[Adagrasib (MRTX849)]]
 
 
*[[Adavosertib (MK-1775)]]
 
*[[Adavosertib (MK-1775)]]
−
*[[Adenovirus-interferon-γ (TG1042)]]
+
*[[Adebrelimab (SHR-1316)]]
−
*[[Afuresertib (GSK2110183)]]
+
*[[Adenovirus-interferon-γ (TG-1042)]]
−
*[[Alisertib (MLN8237)]]
+
*[[Afamitresgene Autoleucel (ADP-A2M4)]]
 +
*[[Afuresertib (GSK-2110183)]]
 +
*[[Agatolimod (PF-3512676)]]
 +
*[[Alisertib (MLN-8237)]]
 
*[[Amatuximab (MORAb-009)]]
 
*[[Amatuximab (MORAb-009)]]
−
*[[AMG 330]]
 
 
*[[Amonafide (Quinamed)]]
 
*[[Amonafide (Quinamed)]]
−
*[[Apocept (APG101)]]
+
*[[Apocept (APG-101)]]
−
*[[Astuprotimut-R (GSK1572932A)]]
+
*[[Astuprotimut-R (GSK-1572932A)]]
  
 
==B==
 
==B==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
+
*[[Barasertib (AZD-1152)]]
−
|[[#top|back to top]]
+
*[[Bavituximab (PGN-401)]]
−
|}
+
*[[Befotertinib (D-0316)]]
−
*[[Barasertib (AZD1152)]]
 
−
*[[Bavituximab (PGN401)]]
 
 
*[[Belagenpumatucel-L (Lucanix)]]
 
*[[Belagenpumatucel-L (Lucanix)]]
−
*[[BHQ880]]
+
*[[BE-CAR7]]
 +
*[[BHQ-880]]
 +
*[[Birtamimab (NEOD-001)]]
 
*[[BL22 immunotoxin (CAT-3888)]]
 
*[[BL22 immunotoxin (CAT-3888)]]
−
*[[Buparlisib (BKM120)]]
+
*[[Buparlisib (BKM-120)]]
  
 
==C==
 
==C==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[CARv3-TEAM-E T-cells]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
−
*[[Capivasertib (AZD5363)]]
 
 
*[[Catumaxomab (Removab)]] '''in US clinical trials'''
 
*[[Catumaxomab (Removab)]] '''in US clinical trials'''
 
*[[Cediranib (Recentin)]]
 
*[[Cediranib (Recentin)]]
 
*[[Cixutumumab (IMC-A12)]]
 
*[[Cixutumumab (IMC-A12)]]
−
*[[Coltuximab ravtansine (CoR, SAR3419)]]
+
*[[Coltuximab ravtansine (SAR-3419)]]
 
*[[Crenolanib (CP-868,596)]]
 
*[[Crenolanib (CP-868,596)]]
 
*[[Custirsen (OGX-011)]]
 
*[[Custirsen (OGX-011)]]
  
 
==D==
 
==D==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
+
*[[Dalpiciclib (SHR-6390)]]
−
|[[#top|back to top]]
+
*[[Danicopan (ALXN-2040)]]
−
|}
+
*[[Datopotamab deruxtecan (DS-1062)]]
−
*[[Dalpiciclib (SHR6390)]]
 
 
*[[Denintuzumab mafodotin (SGN-CD19A)]]
 
*[[Denintuzumab mafodotin (SGN-CD19A)]]
−
*[[Dinaciclib (SCH 727965)]]
+
*[[Dinaciclib (SCH-727965)]]
−
*[[Discodermolide (XAA296)]]
+
*[[Divarasib (GDC-6036)]]
−
*[[DMUC5754A]]
+
*[[Discodermolide (XAA-296)]]
 +
*[[DMUC-5754A]]
 
*[[Dovitinib (TKI-258)]]
 
*[[Dovitinib (TKI-258)]]
  
 
==E==
 
==E==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Emepepimut-S (Stimuvax)]]
 
*[[Emepepimut-S (Stimuvax)]]
−
*[[Ensartinib (X-396)]]
+
*[[Eluvixtamab (AMG-330)]]
 
*[[Entinostat (SNDX-275)]]
 
*[[Entinostat (SNDX-275)]]
 
*[[Entospletinib (GS-9973)]]
 
*[[Entospletinib (GS-9973)]]
−
*[[Epcoritamab (GEN-3013)]]
+
*[[Envonalkib (TQ-B3139)]]
 
*[[Epratuzumab (LymphoCide)]]
 
*[[Epratuzumab (LymphoCide)]]
 
*[[Etirinotecan pegol (NKTR-102)]]
 
*[[Etirinotecan pegol (NKTR-102)]]
  
 
==F==
 
==F==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Farletuzumab (MORAb-003)]]
−
|-
+
*[[Figitumumab (CP-751,871)]]
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Filanesib (ARRY-520)]]
 
*[[Filanesib (ARRY-520)]]
−
*[[Flumatinib (HH-GV-678)]]
 
−
*[[Forodesine (Fodosine)]]
 
−
*[[Fotemustine (Muphoran)]]
 
−
*[[Fruquintinib (HMPL-013)]]
 
−
*[[Futibatinib (TAS-120)]]
 
  
 
==G==
 
==G==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[G207]]
 
*[[G207]]
 
*[[Galeterone (TOK-001)]]
 
*[[Galeterone (TOK-001)]]
−
*[[Galunisertib (LY2157299)]]
+
*[[Galunisertib (LY-2157299)]]
 
*[[Ganetespib (STA-9090)]]
 
*[[Ganetespib (STA-9090)]]
−
*[[Ganitumab (AMG 479)]]
+
*[[Ganitumab (AMG-479)]]
−
*[[Gemcitabine elaidate (CP-4126, CO-101)]]
+
*[[GD2-CART01]]
−
*[[Glembatumumab vedotin (CDX-011)]]]
+
*[[Gemcitabine elaidate (CP-4126)]]
 +
*[[Glembatumumab vedotin (CDX-011)]]
 
*[[Guadecitabine (SGI-110)]]
 
*[[Guadecitabine (SGI-110)]]
  
 
==H==
 
==H==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[HER2 peptide vaccine (AE37)]]
 
*[[HER2 peptide vaccine (AE37)]]
 
*[[Hu5F9-G4]]
 
*[[Hu5F9-G4]]
  
 
==I==
 
==I==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
+
*[[Idasanutlin (RG-7388)]]
−
|[[#top|back to top]]
+
*[[IMA-901]]
−
|}
+
*[[Indatuximab ravtansine (BT-062)]]
−
*[[Idasanutlin (RG7388)]]
 
−
*[[IMA901]]
 
−
*[[Imetelstat (GRN163L)]]
 
−
*[[Indatuximab ravtansine (BT062)]]
 
 
*[[Ipatasertib (GDC-0068)]]
 
*[[Ipatasertib (GDC-0068)]]
−
*[[IPH 2101]]
+
*[[IPH-2101]]
  
 
==J==
 
==J==
Line 729: Line 673:
  
 
==L==
 
==L==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Lapuleucel-T (DN24-02)]]
 
*[[Lapuleucel-T (DN24-02)]]
 
*[[Lestaurtinib (CEP-701)]]
 
*[[Lestaurtinib (CEP-701)]]
Line 739: Line 680:
 
*[[Lorvotuzumab mertansine (BB-10901)]]
 
*[[Lorvotuzumab mertansine (BB-10901)]]
 
*[[Lutetium-177-PSMA-617]]
 
*[[Lutetium-177-PSMA-617]]
−
*[[LY3023414]]
+
*[[LY-3023414]]
  
 
==M==
 
==M==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Magrolimab (Hu5F9-G4)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Mapatumumab (HGS-ETR1)]]
 
*[[Mapatumumab (HGS-ETR1)]]
−
*[[Masitinib (AB1010)]]
+
*[[Masitinib (AB-1010)]]
−
*[[Milataxel (TL139)]]
+
*[[MCARH-109]]
−
*[[Mirvetuximab soravtansine (IMGN853)]]
+
*[[Mezigdomide (BMS-986348)]]
−
*[[MK2206]]
+
*[[Milataxel (TL-139)]]
−
*[[Mocetinostat (MGCD0103)]]
+
*[[MK-2206]]
−
*[[Momelotinib (CYT387)]]
+
*[[Mocetinostat (MGCD-0103)]]
−
*[[MOR208]]
+
*[[Motesanib (AMG-706)]]
−
*[[Motesanib (AMG 706)]]
+
 
 +
==N==
 +
*[[Nolatrexed (Thymitaq)]]
  
 
==O==
 
==O==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Oblimersen (Genasense)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Olaptesed pegol (NOX-A12)]]
 
*[[Olaptesed pegol (NOX-A12)]]
 
*[[Onartuzumab (MetMAb)]]
 
*[[Onartuzumab (MetMAb)]]
−
*[[Oprozomib (ONX 0912)]]
+
*[[Oprozomib (ONX-0912)]]
 
*[[Orteronel (TAK-700)]]
 
*[[Orteronel (TAK-700)]]
−
*[[Osocimab (BAY 1213790)]]
+
*[[Osocimab (BAY-1213790)]]
 
*[[Otlertuzumab (TRU-016)]]
 
*[[Otlertuzumab (TRU-016)]]
  
 
==P==
 
==P==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Patritumab deruxtecan (U3-1402)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
−
*[[Pacritinib (SB1518)]]
 
 
*[[Pentraxin 2 (PRM-151)]]
 
*[[Pentraxin 2 (PRM-151)]]
 
*[[Perifosine (KRX-0401)]]
 
*[[Perifosine (KRX-0401)]]
Line 779: Line 712:
 
*[[Pictilisib (GDC-0941)]]
 
*[[Pictilisib (GDC-0941)]]
 
*[[Pidilizumab (CT-011)]]
 
*[[Pidilizumab (CT-011)]]
−
*[[Pinatuzumab vedotin (DCDT2980S)]]
+
*[[Pimitespib (TAS-116)]]
−
*[[Pirtobrutinib (LOXO-305)]]
+
*[[Pinatuzumab vedotin (DCDT-2980S)]]
 
*[[Plinabulin (NPI-2358)]]
 
*[[Plinabulin (NPI-2358)]]
−
*[[Pracinostat (SB939)]]
+
*[[Pracinostat (SB-939)]]
  
 
==Q==
 
==Q==
 
*[[Quisinostat (JNJ-26481585)]]
 
*[[Quisinostat (JNJ-26481585)]]
−
*[[Quizartinib (AC220)]]
 
  
 
==R==
 
==R==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Rebimastat (BMS-275291)]]
−
|-
+
*[[Refametinib (BAY-869766)]]
−
|[[#top|back to top]]
 
−
|}
 
−
*[[Refametinib (BAY 869766)]]
 
 
*[[Reovirus (Reolysin)]]
 
*[[Reovirus (Reolysin)]]
 
*[[Retaspimycin (IPI-504)]]
 
*[[Retaspimycin (IPI-504)]]
−
*[[Ricolinostat (ACY-1215, Rocilinostat)]]
+
*[[Revumenib (SNDX-5613)]]
−
*[[Ridaforolimus (AP23573)]]
+
*[[Rezvilutamide (SHR-3680)]]
−
*[[Rilotumumab (AMG 102)]]
+
*[[Ricolinostat (ACY-1215)]]
 +
*[[Ridaforolimus (AP-23573)]]
 +
*[[Rilotumumab (AMG-102)]]
 +
*[[Ripertamab (SCT-400)]]
 
*[[Rociletinib (CO-1686)]]
 
*[[Rociletinib (CO-1686)]]
−
*[[Ropeginterferon alfa-2b (AOP2014)]]
 
  
 
==S==
 
==S==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Sapacitabine (CS-682)]]
 
*[[Sapacitabine (CS-682)]]
−
*[[Sapanisertib (MLN0128)]]
+
*[[Sapanisertib (MLN-0128)]]
−
*[[Seliciclib (CYC202)]]
+
*[[Seliciclib (CYC-202)]]
−
*[[Semuloparin (AVE5026)]]
+
*[[Semuloparin (AVE-5026)]]
−
*[[Sintilimab (IBI 308)]]
 
 
*[[Spebrutinib (CC-292)]]
 
*[[Spebrutinib (CC-292)]]
 
*[[Surufatinib (HMPL-012)]]
 
*[[Surufatinib (HMPL-012)]]
−
*[[Sutimlimab (BIVV009)]]
 
  
 
==T==
 
==T==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
+
*[[Tabalumab (LY-2127399)]]
−
|[[#top|back to top]]
+
*[[Tasadenoturev (DNX-2401)]]
−
|}
+
*[[Telisotuzumab vedotin (ABBV-399)]]
−
*[[Tabalumab (LY2127399)]]
+
*[[Tertomotide (GV-1001)]]
−
*[[Tamibarotene (Amnoid)]]
 
−
*[[Tebentafusp (IMCgp100)]]
 
−
*[[Teclistamab (JNJ 64007957)]]
 
 
*[[Tesetaxel (DJ-927)]]
 
*[[Tesetaxel (DJ-927)]]
−
*[[Tesevatinib (XL647)]]
+
*[[Tesevatinib (XL-647)]]
 
*[[Tigatuzumab (CS-1008)]]
 
*[[Tigatuzumab (CS-1008)]]
 
*[[Tipifarnib (Zarnestra)]]
 
*[[Tipifarnib (Zarnestra)]]
−
*[[Tirabrutinib (GS-4059)]]
+
*[[Tirapazamine (Tirazone)]]
−
*[[Tislelizumab (BGB-A317)]]
+
*[[Tislelizumab (Baizean)]]
−
*[[Tivantinib (ARQ 197)]]
+
*[[Tivantinib (ARQ-197)]]
 
*[[Tivozanib (AV-951)]]
 
*[[Tivozanib (AV-951)]]
−
*[[Toripalimab (JS001)]]
 
 
*[[Tosedostat (CHR-2797)]]
 
*[[Tosedostat (CHR-2797)]]
−
*[[Trebananib (AMG 386)]]
+
*[[Trebananib (AMG-386)]]
−
*[[Tremelimumab (ticilimumab)]]
+
*[[Tusamitamab ravtansine (SAR-408701)]]
  
 
==U==
 
==U==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
−
*[[Ublituximab (TG-1101)]]
 
 
*[[UCART19]]
 
*[[UCART19]]
  
 
==V==
 
==V==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Vadastuximab talirine (SGN-CD33A)]]
 
*[[Vadastuximab talirine (SGN-CD33A)]]
 +
*[[Vadimezan (AS-A404)]]
 
*[[Varlilumab (CDX-1127)]]
 
*[[Varlilumab (CDX-1127)]]
 
*[[Veliparib (ABT-888)]]
 
*[[Veliparib (ABT-888)]]
 
*[[Veltuzumab (hA20)]]
 
*[[Veltuzumab (hA20)]]
−
*[[Volasertib (BI 6727)]]
+
*[[Volasertib (BI-6727)]]
−
*[[Vosaroxin (SNS 595)]]
+
*[[Vorasidenib (AG-881)]]
−
*[[Voxtalisib (XL765)]]
+
*[[Vorolanib (CM-082)]]
 +
*[[Vosaroxin (SNS-595)]]
 +
*[[Voxtalisib (XL-765)]]
  
 
==Z==
 
==Z==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Zandelisib (ME-401)]]
 
*[[Zandelisib (ME-401)]]
 +
*[[Zolbetuximab (IMAB-362)]]
  
 
=Supportive and other medications=
 
=Supportive and other medications=
 +
''This section contains supportive drugs that are either approved or investigational. Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound.''
 +
==A==
  
−
==A==
 
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Abciximab (ReoPro)]]
 
*[[Abciximab (ReoPro)]]
 
*[[Acetaminophen (Tylenol)]]
 
*[[Acetaminophen (Tylenol)]]
 
*[[Acetazolamide (Diamox)]]
 
*[[Acetazolamide (Diamox)]]
 
*[[Acyclovir (Zovirax)]]
 
*[[Acyclovir (Zovirax)]]
 +
*[[ADAMTS13, recombinant (Adzynma)]]
 
*[[Alendronate (Fosamax)]]
 
*[[Alendronate (Fosamax)]]
 
*[[Alizapride (Litican)]]
 
*[[Alizapride (Litican)]]
Line 884: Line 797:
 
*[[Amoxicillin]]
 
*[[Amoxicillin]]
 
*[[Anagrelide (Agrylin)]]
 
*[[Anagrelide (Agrylin)]]
 +
*[[Andexanet alfa (Andexxa)]]
 
*[[Anti-inhibitor coagulant complex (FEIBA NF)]]
 
*[[Anti-inhibitor coagulant complex (FEIBA NF)]]
 
*[[Antithrombin III (human and recombinant)]]
 
*[[Antithrombin III (human and recombinant)]]
Line 902: Line 816:
  
 
==B==
 
==B==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
*[[Betibeglogene autotemcel (Zynteglo)]]
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Betrixaban (Bevyxxa)]]
 
*[[Betrixaban (Bevyxxa)]]
 
*[[Bismuth subsalicylate (Pepto-Bismol)]]
 
*[[Bismuth subsalicylate (Pepto-Bismol)]]
Line 911: Line 822:
  
 
==C==
 
==C==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Cangrelor (Kengreal)]]
 
*[[Cangrelor (Kengreal)]]
 
*[[Calcium phosphate rinse (Caphosol)]]
 
*[[Calcium phosphate rinse (Caphosol)]]
 +
*[[Caspofungin (Cancidas)]]
 
*[[Cetirizine (Zyrtec)]]
 
*[[Cetirizine (Zyrtec)]]
 
*[[Chlorpheniramine (Chlor-Trimeton)]]
 
*[[Chlorpheniramine (Chlor-Trimeton)]]
Line 926: Line 835:
 
*[[Clodronate (Bonefos)]]
 
*[[Clodronate (Bonefos)]]
 
*[[Clopidogrel (Plavix)]]
 
*[[Clopidogrel (Plavix)]]
 +
*[[Concizumab (Alhemo)]]
 
*[[Crizanlizumab (Adakveo)]]
 
*[[Crizanlizumab (Adakveo)]]
 
*[[Cyanocobalamin (Vitamin B12)]]
 
*[[Cyanocobalamin (Vitamin B12)]]
Line 932: Line 842:
  
 
==D==
 
==D==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Dabigatran (Pradaxa)]]
 
*[[Dabigatran (Pradaxa)]]
 
*[[Dalteparin (Fragmin)]]
 
*[[Dalteparin (Fragmin)]]
Line 947: Line 854:
 
*[[Defibrotide (Defitelio)]]
 
*[[Defibrotide (Defitelio)]]
 
*[[Denosumab (Xgeva)]]
 
*[[Denosumab (Xgeva)]]
 +
**[[Denosumab-bddz (Wyost)]]
 
*[[Desmopressin (DDAVP)]]
 
*[[Desmopressin (DDAVP)]]
 
*[[Dexchlorpheniramine (Polaramine)]]
 
*[[Dexchlorpheniramine (Polaramine)]]
Line 959: Line 867:
  
 
==E==
 
==E==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Eculizumab (Soliris)]]
 
*[[Eculizumab (Soliris)]]
 +
**[[Eculizumab-beke (Bekemv)]]
 +
**[[Eculizumab-epys (Epysqli)]]
 
*[[Edoxaban (Savaysa)]]
 
*[[Edoxaban (Savaysa)]]
 +
*[[Efanesoctocog alfa (Altuviiio)]]
 +
*[[Eflapegrastim (Rolvedon)]]
 
*[[Eltrombopag (Promacta)]]
 
*[[Eltrombopag (Promacta)]]
−
*[[Emicizumab-kxwh (Hemlibra)]]
+
*[[Emicizumab (Hemlibra)]]
 
*[[Enoxaparin (Lovenox)]]
 
*[[Enoxaparin (Lovenox)]]
−
**[[Enoxaparin (Inhixa)]]
+
**[[Enoxaparin-inhi (Inhixa)]]
 
*[[Epoetin alfa (Procrit)]]
 
*[[Epoetin alfa (Procrit)]]
 
**[[Epoetin alfa-epbx (Retacrit)]]
 
**[[Epoetin alfa-epbx (Retacrit)]]
−
**[[Epoetin alfa (Abseamed)]]
+
**[[Epoetin alfa-abse (Abseamed)]]
−
**[[Epoetin alfa (Binocrit)]]
+
**[[Epoetin alfa-bino (Binocrit)]]
−
**[[Epoetin alfa (Epoetin Alfa Hexal)]]
+
**[[Epoetin alfa-hexa (Epoetin Alfa Hexal)]]
 +
*[[Epoetin theta (Biopoin)]]
 
*[[Epoetin zeta (Eprex)]]
 
*[[Epoetin zeta (Eprex)]]
−
**[[Epoetin zeta (Silapo)]]
+
**[[Epoetin zeta-reta (Retacrit)]]
 +
**[[Epoetin zeta-sila (Silapo)]]
 
*[[Eptifibatide (Integrilin)]]
 
*[[Eptifibatide (Integrilin)]]
 +
*[[Etranacogene dezaparvovec (Hemgenix)]]
 +
*[[Exagamglogene autotemcel (Casgevy)]] '''FDA approved on 2023-12-08'''
  
 
==F==
 
==F==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Factor VIIa, recombinant (NovoSeven RT)]]
 
*[[Factor VIIa, recombinant (NovoSeven RT)]]
 
*[[Factor VIII, human]]
 
*[[Factor VIII, human]]
Line 990: Line 899:
 
*[[Factor IX, recombinant, Fc fusion protein (Alprolix)]]
 
*[[Factor IX, recombinant, Fc fusion protein (Alprolix)]]
 
*[[Factor X, human (Coagadex)]]
 
*[[Factor X, human (Coagadex)]]
−
*[[Factor Xa, recombinant, inactivated-zhzo (Andexxa)]]
 
 
*[[Factor XIII concentrate, human (Corifact)]]
 
*[[Factor XIII concentrate, human (Corifact)]]
 
*[[Famciclovir (Famvir)]]
 
*[[Famciclovir (Famvir)]]
 
*[[Famotidine (Pepcid)]]
 
*[[Famotidine (Pepcid)]]
 
*[[Ferric carboxymaltose (Injectafer)]]
 
*[[Ferric carboxymaltose (Injectafer)]]
 +
*[[Ferric derisomaltose (Monoferric)]]
 
*[[Ferric gluconate (Ferrlecit)]]
 
*[[Ferric gluconate (Ferrlecit)]]
 
*[[Ferrous sulfate (Feosol)]]
 
*[[Ferrous sulfate (Feosol)]]
Line 1,001: Line 910:
 
*[[Filgrastim (Neupogen)]]
 
*[[Filgrastim (Neupogen)]]
 
**[[Filgrastim-aafi (Nivestym)]]
 
**[[Filgrastim-aafi (Nivestym)]]
 +
**[[Filgrastim-ayow (Releuko)]]
 
**[[Filgrastim-sndz (Zarxio)]]
 
**[[Filgrastim-sndz (Zarxio)]]
−
**[[Filgrastim (Accofil)]]
+
**[[Filgrastim-acco (Accofil)]]
−
**[[Filgrastim (Filgrastim Hexal)]]
+
**[[Filgrastim-hexa (Filgrastim Hexal)]]
−
**[[Filgrastim (Grastofil)]]
+
**[[Filgrastim-gras (Grastofil)]]
−
**[[Filgrastim (Ratiograstim)]]
+
**[[Filgrastim-rati (Ratiograstim)]]
−
**[[Filgrastim (Tevagrastim)]]
+
**[[Filgrastim-teva (Tevagrastim)]]
 
*[[Finasteride (Proscar)]]
 
*[[Finasteride (Proscar)]]
 +
*[[Fitusiran (ALN-AT3SC)]]
 
*[[Fluconazole (Diflucan)]]
 
*[[Fluconazole (Diflucan)]]
 
*[[Folic acid (Folate)]]
 
*[[Folic acid (Folate)]]
 
*[[Fondaparinux (Arixtra)]]
 
*[[Fondaparinux (Arixtra)]]
 
*[[Fosaprepitant (Emend for Injection)]]
 
*[[Fosaprepitant (Emend for Injection)]]
 +
*[[Fosnetupitant (Arokaris)]]
 
*[[Furosemide (Lasix)]]
 
*[[Furosemide (Lasix)]]
  
 
==G==
 
==G==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Glucarpidase (Voraxaze)]]
 
*[[Glucarpidase (Voraxaze)]]
−
*[[Granisetron (Kytril)]]
+
*[[Granisetron]]
−
*[[Granisetron (Sancuso)]]
 
−
*[[Granisetron (Sustol)]]
 
  
 
==H==
 
==H==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Haloperidol (Haldol)]]
 
*[[Haloperidol (Haldol)]]
 
*[[Hematopoetic progenitor cells, cord blood (Hemacord)]]
 
*[[Hematopoetic progenitor cells, cord blood (Hemacord)]]
  
 
==I==
 
==I==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Ibandronate (Boniva)]]
 
*[[Ibandronate (Boniva)]]
 
*[[Idarucizumab (Praxbind)]]
 
*[[Idarucizumab (Praxbind)]]
 
*[[Indomethacin (Indocin)]]
 
*[[Indomethacin (Indocin)]]
 +
*[[Iptacopan (Fabhalta)]] '''FDA approved 2023-12-05'''
 
*[[Iron dextran (INFeD)]]
 
*[[Iron dextran (INFeD)]]
 
*[[Iron sucrose (Venofer)]]
 
*[[Iron sucrose (Venofer)]]
Line 1,045: Line 947:
  
 
==L==
 
==L==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Lactulose]]
 
*[[Lactulose]]
 
*[[Lamivudine (Epivir)]]
 
*[[Lamivudine (Epivir)]]
Line 1,054: Line 953:
 
*[[Lenograstim (Granocyte)]]
 
*[[Lenograstim (Granocyte)]]
 
*[[Lepirudin (Refludan)]] '''discontinued'''
 
*[[Lepirudin (Refludan)]] '''discontinued'''
 +
*[[Letermovir (Prevymis)]]
 
*[[Levofloxacin (Levaquin)]]
 
*[[Levofloxacin (Levaquin)]]
 
*[[L-glutamine (Endari)]]
 
*[[L-glutamine (Endari)]]
−
*[[Lipefilgrastim (XM22)]] '''in clinical trials'''
+
*[[Lipefilgrastim (Lonquex)]]
 
*[[Loperamide (Imodium)]]
 
*[[Loperamide (Imodium)]]
 
*[[Lorazepam (Ativan)]]
 
*[[Lorazepam (Ativan)]]
 +
*[[Lovotibeglogene autotemcel (Lyfgenia)]] '''FDA approved on 2023-12-08'''
 
*[[Luspatercept (Reblozyl)]]
 
*[[Luspatercept (Reblozyl)]]
 
*[[Lusutrombopag (Mulpleta)]]
 
*[[Lusutrombopag (Mulpleta)]]
  
 
==M==
 
==M==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Mannitol]]
 
*[[Mannitol]]
Line 1,073: Line 971:
 
*[[Methyltesterone (Android)]]
 
*[[Methyltesterone (Android)]]
 
*[[Metoclopramide (Reglan)]]
 
*[[Metoclopramide (Reglan)]]
−
*[[Mitapivat (AG-348)]] '''in clinical trials'''
+
*[[Mitapivat (Pyrukynd)]]
 +
*[[Motixafortide (Aphexda)]] '''FDA approved 2023-09'''
 
*[[Mycophenolate mofetil (CellCept)]]
 
*[[Mycophenolate mofetil (CellCept)]]
  
 
==N==
 
==N==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Nabilone (Cesamet)]]
 
*[[Nabilone (Cesamet)]]
 
*[[Netupitant and palonosetron (Akynzeo)]]
 
*[[Netupitant and palonosetron (Akynzeo)]]
 +
*[[Nonacog beta pegol (Refixia)]]
  
 
==O==
 
==O==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Olanzapine (Zyprexa)]]
 
*[[Olanzapine (Zyprexa)]]
 
*[[Omeprazole (Prilosec)]]
 
*[[Omeprazole (Prilosec)]]
 +
*[[Omidubicel (Omisirge)]] '''FDA approved 2023-04-17'''
 
*[[Ondansetron (Zofran)]]
 
*[[Ondansetron (Zofran)]]
 
*[[Oprelvekin (Neumega)]]
 
*[[Oprelvekin (Neumega)]]
  
 
==P==
 
==P==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Palifermin (Kepivance)]]
 
*[[Palifermin (Kepivance)]]
Line 1,109: Line 1,001:
 
**[[Pegfilgrastim-bmez (Ziextenzo)]]
 
**[[Pegfilgrastim-bmez (Ziextenzo)]]
 
**[[Pegfilgrastim-cbqv (Udenyca)]]
 
**[[Pegfilgrastim-cbqv (Udenyca)]]
 +
**[[Pegfilgrastim-fpgk (Stimufend)]]
 
**[[Pegfilgrastim-jmdb (Fulphila)]]
 
**[[Pegfilgrastim-jmdb (Fulphila)]]
−
**[[Pegfilgrastim (Cegfila)]]
+
**[[Pegfilgrastim-cegf (Cegfila)]]
−
**[[Pegfilgrastim (Grasustek)]]
+
**[[Pegfilgrastim-gras (Grasustek)]]
−
**[[Pegfilgrastim (Pelgraz)]]
+
**[[Pegfilgrastim-pbbk (Fylnetra)]]
−
**[[Pegfilgrastim (Pelmeg)]]
+
**[[Pegfilgrastim-pelg (Pelgraz)]]
 +
**[[Pegfilgrastim-pelm (Pelmeg)]]
 +
**[[Pegfilgrastim-stim (Stimufend)]]
 
*[[Penicillin V]]
 
*[[Penicillin V]]
 
*[[Pentamidine (Nebupent)]]
 
*[[Pentamidine (Nebupent)]]
Line 1,124: Line 1,019:
 
*[[Promethazine (Phenergan)]]
 
*[[Promethazine (Phenergan)]]
 
*[[Protamine sulfate]]
 
*[[Protamine sulfate]]
 +
*[[Protein C, human (Ceprotin)]]
 
*[[Prothrombin Complex Concentrate, human]]
 
*[[Prothrombin Complex Concentrate, human]]
  
Line 1,131: Line 1,027:
  
 
==R==
 
==R==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
−
 
 
*[[Rabeprazole (Aciphex)]]
 
*[[Rabeprazole (Aciphex)]]
 
*[[Raloxifene (Evista)]]
 
*[[Raloxifene (Evista)]]
Line 1,141: Line 1,032:
 
*[[Ranitidine (Zantac)]]
 
*[[Ranitidine (Zantac)]]
 
*[[Rasburicase (Elitek)]]
 
*[[Rasburicase (Elitek)]]
 +
*[[Remestemcel-L (Prochymal)]]
 
*[[Rho(D) immune globulin (RhoGAM)]]
 
*[[Rho(D) immune globulin (RhoGAM)]]
 +
*[[Rilzabrutinib (PRN-1008)]]
 
*[[Risedronate (Actonel)]]
 
*[[Risedronate (Actonel)]]
 
*[[Rivaroxaban (Xarelto)]]
 
*[[Rivaroxaban (Xarelto)]]
 
*[[Rolapitant (Varubi)]]
 
*[[Rolapitant (Varubi)]]
 
*[[Romiplostim (Nplate)]]
 
*[[Romiplostim (Nplate)]]
 +
*[[Rusfertide (PTG-300)]]
  
 
==S==
 
==S==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Sargramostim (Leukine)]]
 
*[[Sargramostim (Leukine)]]
 
*[[Scopolamine (Scopoderm)]]
 
*[[Scopolamine (Scopoderm)]]
Line 1,157: Line 1,048:
 
*[[Siltuximab (Sylvant)]]
 
*[[Siltuximab (Sylvant)]]
 
*[[Sirolimus (Rapamune)]]
 
*[[Sirolimus (Rapamune)]]
 +
*[[Sodium thiosulfate (Pedmark)]]
 +
*[[Sutimlimab (Enjaymo)]]
  
 
==T==
 
==T==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Tacrolimus (Prograf)]]
 
*[[Tacrolimus (Prograf)]]
 
*[[Tbo-filgrastim (Granix)]]
 
*[[Tbo-filgrastim (Granix)]]
 +
*[[Telotristat (Xermelo)]]
 
*[[Ticagrelor (Brilinta)]]
 
*[[Ticagrelor (Brilinta)]]
−
*[[Ticlodipine (Ticlid)]]
+
*[[Ticlopidine (Ticlid)]]
 
*[[Tinzaparin (Innohep)]]
 
*[[Tinzaparin (Innohep)]]
 
*[[Tirofiban (Aggrastat)]]
 
*[[Tirofiban (Aggrastat)]]
 
*[[Tocilizumab (Actemra)]]
 
*[[Tocilizumab (Actemra)]]
 +
**[[Tocilizumab-aazg (Tyenne)]]
 +
**[[Tocilizumab-bavi (Tofidence)]]
 
*[[Tofacitinib (Xeljanz)]]
 
*[[Tofacitinib (Xeljanz)]]
 
*[[Tranexamic acid (Cyklokapron)]]
 
*[[Tranexamic acid (Cyklokapron)]]
 +
*[[Trilaciclib (Cosela)]]
 
*[[Trimethoprim-Sulfamethoxazole (Bactrim DS)]]
 
*[[Trimethoprim-Sulfamethoxazole (Bactrim DS)]]
 
*[[Tropisetron (Navoban)]]
 
*[[Tropisetron (Navoban)]]
Line 1,180: Line 1,074:
  
 
==V==
 
==V==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
*[[Valacyclovir (Valtrex)]]
 
*[[Valacyclovir (Valtrex)]]
 
*[[Valganciclovir (Valcyte)]]
 
*[[Valganciclovir (Valcyte)]]
 
*[[Valoctocogene roxaparvovec (AAV5-hFVIII-SQ)]]
 
*[[Valoctocogene roxaparvovec (AAV5-hFVIII-SQ)]]
 
*[[Valproate (Depakote)]]
 
*[[Valproate (Depakote)]]
 +
*[[Verbrinacogene setparvovec (FLT-180a)]]
 
*[[von Willebrand factor and factor VIII complex, human]]
 
*[[von Willebrand factor and factor VIII complex, human]]
 
*[[von Willebrand factor, recombinant]]
 
*[[von Willebrand factor, recombinant]]
 +
*[[Vonoprazan (Takecab)]]
 
*[[Vorapaxar (Zontivity)]]
 
*[[Vorapaxar (Zontivity)]]
 
*[[Voriconazole (Vfend)]]
 
*[[Voriconazole (Vfend)]]
  
 
==W==
 
==W==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Warfarin (Coumadin)]]
 
*[[Warfarin (Coumadin)]]
Line 1,205: Line 1,095:
  
 
=By Category=
 
=By Category=
−
''Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is still in process so not all of these links are active).''
+
''Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is an ongoing process so not all of these links are active or current).''
  
 
==[[:Category:REMS_program|Drugs in a REMS program]]==
 
==[[:Category:REMS_program|Drugs in a REMS program]]==
  
 
==Cytotoxic Chemotherapy==
 
==Cytotoxic Chemotherapy==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:Alkylating agents|Alkylating agents]]
 
*[[:Category:Alkylating agents|Alkylating agents]]
Line 1,229: Line 1,116:
  
 
==[[:Category:Kinase inhibitors|Kinase inhibitors]]==
 
==[[:Category:Kinase inhibitors|Kinase inhibitors]]==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
 
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
 
*[[:Category:AKT1 inhibitors|AKT1 inhibitors]]
 
*[[:Category:AKT1 inhibitors|AKT1 inhibitors]]
Line 1,266: Line 1,150:
  
 
==[[:Category:Endocrine therapeutic|Endocrine therapy]]==
 
==[[:Category:Endocrine therapeutic|Endocrine therapy]]==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:Antiandrogens|Antiandrogens]]
 
*[[:Category:Antiandrogens|Antiandrogens]]
Line 1,288: Line 1,169:
  
 
==Biologics==
 
==Biologics==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:Antibody medications|Antibody medications]]
 
*[[:Category:Antibody medications|Antibody medications]]
Line 1,302: Line 1,180:
  
 
==Supportive Medications==
 
==Supportive Medications==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:Antibacterials|Antibacterials]]
 
*[[:Category:Antibacterials|Antibacterials]]
Line 1,325: Line 1,200:
  
 
==[[:Category:Hematology medications|Benign Hematology Medications]]==
 
==[[:Category:Hematology medications|Benign Hematology Medications]]==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:Anticoagulants|Anticoagulants]]
 
*[[:Category:Anticoagulants|Anticoagulants]]
Line 1,347: Line 1,219:
  
 
==[[:Category:Hematopoietic growth factors|Hematopoietic Growth Factors]]==
 
==[[:Category:Hematopoietic growth factors|Hematopoietic Growth Factors]]==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:Erythrocyte growth factors|Erythrocyte growth factors]]
 
*[[:Category:Erythrocyte growth factors|Erythrocyte growth factors]]
Line 1,357: Line 1,226:
  
 
==Miscellaneous==
 
==Miscellaneous==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:REMS_program|Drugs in a REMS program]]
 
*[[:Category:REMS_program|Drugs in a REMS program]]
Line 1,369: Line 1,235:
  
 
==Medications by Condition==
 
==Medications by Condition==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
<div style="column-count:3;-moz-column-count:3;-webkit-column-count:3">
 
<div style="column-count:3;-moz-column-count:3;-webkit-column-count:3">
 
*[[:Category:B-cell acute lymphoblastic leukemia medications|Acute lymphocytic leukemia medications]]
 
*[[:Category:B-cell acute lymphoblastic leukemia medications|Acute lymphocytic leukemia medications]]
Line 1,379: Line 1,242:
 
*[[:Category:Anal cancer medications|Anal cancer medications]]
 
*[[:Category:Anal cancer medications|Anal cancer medications]]
 
*[[:Category:Anaplastic large cell lymphoma medications|Anaplastic large cell lymphoma medications]]
 
*[[:Category:Anaplastic large cell lymphoma medications|Anaplastic large cell lymphoma medications]]
−
*[[:Category:Basal cell and squamous cell skin cancer medications|Basal cell and squamous cell skin cancer medications]]
 
 
*[[:Category:Bladder cancer medications|Bladder cancer medications]]
 
*[[:Category:Bladder cancer medications|Bladder cancer medications]]
 
*[[:Category:Bone cancer medications |Bone cancer medications]]
 
*[[:Category:Bone cancer medications |Bone cancer medications]]
Line 1,385: Line 1,247:
 
*[[:Category:Burkitt lymphoma medications|Burkitt lymphoma medications]]
 
*[[:Category:Burkitt lymphoma medications|Burkitt lymphoma medications]]
 
*[[:Category:Cancer of unknown primary medications |Cancer of unknown primary medications]]
 
*[[:Category:Cancer of unknown primary medications |Cancer of unknown primary medications]]
−
*[[:Category:Castleman’s disease medications|Castleman’s disease medications]]
+
*[[:Category:Castleman disease medications|Castleman disease medications]]
 
*[[:Category:Central nervous system (CNS) cancer medications|Central nervous system (CNS) cancer medications]]
 
*[[:Category:Central nervous system (CNS) cancer medications|Central nervous system (CNS) cancer medications]]
 
*[[:Category:CNS lymphoma medications|Central nervous system (CNS) lymphoma medications]]
 
*[[:Category:CNS lymphoma medications|Central nervous system (CNS) lymphoma medications]]
 
*[[:Category:Cervical cancer medications|Cervical cancer medications]]
 
*[[:Category:Cervical cancer medications|Cervical cancer medications]]
 
*[[:Category:Chronic lymphocytic leukemia medications|Chronic lymphocytic leukemia (CLL/SLL) medications]]
 
*[[:Category:Chronic lymphocytic leukemia medications|Chronic lymphocytic leukemia (CLL/SLL) medications]]
−
*[[:Category:Chronic myelogenous leukemia medications|Chronic myelogenous leukemia medications]]
+
*[[:Category:Chronic myeloid leukemia medications|Chronic myeloid leukemia (CML) medications]]
−
*[[:Category:Chronic myelomonocytic leukemia medications|Chronic myelomonocytic leukemia medications]]
+
*[[:Category:Chronic myelomonocytic leukemia medications|Chronic myelomonocytic leukemia (CMML) medications]]
 
*[[:Category:Colon cancer medications|Colon cancer medications]]
 
*[[:Category:Colon cancer medications|Colon cancer medications]]
 +
*[[:Category:Colorectal cancer medications|Colorectal cancer (CRC) medications]]
 +
*[[:Category:Cutaneous basal cell carcinoma medications|Cutaneous BCC medications]]
 +
*[[:Category:Cutaneous squamous cell carcinoma medications|Cutaneous SCC medications]]
 
*[[:Category:Cutaneous T-cell lymphoma medications|Cutaneous T-cell lymphoma medications]]
 
*[[:Category:Cutaneous T-cell lymphoma medications|Cutaneous T-cell lymphoma medications]]
 
*[[:Category:Diffuse large B-cell lymphoma medications|Diffuse large B-cell lymphoma medications]]
 
*[[:Category:Diffuse large B-cell lymphoma medications|Diffuse large B-cell lymphoma medications]]
Line 1,444: Line 1,309:
  
 
==[[:Category:Routed medications|Medications by Route of Administration]]==
 
==[[:Category:Routed medications|Medications by Route of Administration]]==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[:Category:Intra-arterial medications|Intraarterial (IA) medications]]
 
*[[:Category:Intra-arterial medications|Intraarterial (IA) medications]]
Line 1,458: Line 1,320:
 
*[[:Category:Subcutaneous medications|Subcutaneous (SC) medications]]
 
*[[:Category:Subcutaneous medications|Subcutaneous (SC) medications]]
  
−
==Medications by Year of Approval==
+
==Medications by FDA Year of Approval==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
<div style="column-count:3;-moz-column-count:3;-webkit-column-count:3">
 
<div style="column-count:3;-moz-column-count:3;-webkit-column-count:3">
 
*[[:Category:FDA approved in 1939|FDA approved in 1939]]
 
*[[:Category:FDA approved in 1939|FDA approved in 1939]]
Line 1,534: Line 1,393:
 
*[[:Category:FDA approved in 2018|FDA approved in 2018]]
 
*[[:Category:FDA approved in 2018|FDA approved in 2018]]
 
*[[:Category:FDA approved in 2019|FDA approved in 2019]]
 
*[[:Category:FDA approved in 2019|FDA approved in 2019]]
 +
*[[:Category:FDA approved in 2020|FDA approved in 2020]]
 +
*[[:Category:FDA approved in 2021|FDA approved in 2021]]
 +
*[[:Category:FDA approved in 2022|FDA approved in 2022]]
 +
*[[:Category:FDA approved in 2023|FDA approved in 2023]]
 +
*[[:Category:FDA approved in 2024|FDA approved in 2024]]
 
</div>
 
</div>
  
 
=Interesting and Helpful Links=
 
=Interesting and Helpful Links=
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
  
 
*[[Antidepressants and other psychiatric medications in cancer care]]
 
*[[Antidepressants and other psychiatric medications in cancer care]]
Line 1,547: Line 1,408:
 
*[https://doi.org/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society (ASCO/ONS) Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology]
 
*[https://doi.org/10.1200/JOP.2016.017905 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society (ASCO/ONS) Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology]
 
*[http://issuu.com/theoncologypharmacist/docs/jhop_march2011/1?mode=a_p Chemotherapy Administration Sequence]<ref>Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. [http://issuu.com/theoncologypharmacist/docs/jhop_march2011/1?mode=a_p link to original article]</ref> - with chemotherapy sequencing chart
 
*[http://issuu.com/theoncologypharmacist/docs/jhop_march2011/1?mode=a_p Chemotherapy Administration Sequence]<ref>Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. [http://issuu.com/theoncologypharmacist/docs/jhop_march2011/1?mode=a_p link to original article]</ref> - with chemotherapy sequencing chart
−
*[https://onlinelibrary.wiley.com/doi/10.1111/j.1743-7563.2010.01321.x/full The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy.] [https://pubmed.ncbi.nlm.nih.gov/20887505 PubMed]
+
*[https://doi.org/10.1111/j.1743-7563.2010.01321.x The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy.] [https://pubmed.ncbi.nlm.nih.gov/20887505/ PubMed]
 
*[https://crediblemeds.org/ CredibleMeds.org] - lists of QT-prolonging drugs; requires free registration to see full list
 
*[https://crediblemeds.org/ CredibleMeds.org] - lists of QT-prolonging drugs; requires free registration to see full list
 
*[http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm FDA drug shortages list]
 
*[http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm FDA drug shortages list]

Latest revision as of 23:46, 21 June 2024

Back to Top

Guidelines

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.

Other interesting and helpful links can be found by clicking the link.

Chemotherapy safety standards

Dose adjustments

Antimicrobials

Growth factors

Approved antineoplastics

This section contains anticancer drugs that have had at least one formal approval in any domain (FDA, EMA, etc). Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound. For drugs first approved within the current or prior calendar years, the date of initial approval is also provided here.

A

B

C

D

E

F

G

H

I

K

L

M

N

O

P

Q

R

S

T

U

V

Z

Discontinued antineoplastics

This section contains drugs that have had at least one formal approval in any domain (FDA, EMA, etc), but are no longer on the market. Note that it is possible that these drugs continue to be available in some limited way, such as through compassionate use programs.

A

D

E

F

L

M

O

P

S

T

U

V

Investigational antineoplastics

This list is far from exhaustive. Drugs are included here generally once there are some encouraging preliminary results. Since is it very difficult to tell when a company has stopped development on a drug, this list may also include drugs that are no longer under investigation.

A

B

C

D

E

F

G

H

I

J

L

M

N

O

P

Q

R

S

T

U

V

Z

Supportive and other medications

This section contains supportive drugs that are either approved or investigational. Biosimilars are also indexed here, indented below their parent compound. Note that EMA biosimilar approvals do not include the four-letter suffix at this time, which we have added to distinguish the generic ingredient from the parent compound.

A

B

C

D

E

F

G

H

I

L

M

N

O

P

Q

R

S

T

U

V

W

Z

By Category

Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is an ongoing process so not all of these links are active or current).

Drugs in a REMS program

Cytotoxic Chemotherapy

Kinase inhibitors

Endocrine therapy

Investigational and Discontinued

Biologics

Supportive Medications

Radioactive agents

Benign Hematology Medications

Hematopoietic Growth Factors

Miscellaneous

Medications by Condition

Medications by Route of Administration

Medications by FDA Year of Approval

Interesting and Helpful Links

References

  1. ↑ Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. link to original article PubMed
  2. ↑ Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13. link to original article PubMed
  3. ↑ Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. link to original article
Retrieved from "https://hemonc.org/w/index.php?title=Drug_index&oldid=86284"